ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,112.80
0.33%
다우존스 지수
43,428.02
0.00%
Bitcoin
95,936.85
-0.35%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) 뉴스

LQDA

Liquidia (LQDA)

Liquidia Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:LQDA
일자시간출처헤드라인심볼기업
2025/02/1307:34Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LQDALiquidia Corporation
2025/01/2407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2025/01/1506:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2025/01/1506:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2025/01/1506:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2025/01/0822:00GlobeNewswire Inc.Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
2024/12/0411:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/12/0411:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/11/1321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
2024/11/1320:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/11/1320:30GlobeNewswire Inc.Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
2024/11/1222:00GlobeNewswire Inc.Liquidia to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
2024/11/0622:00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024NASDAQ:LQDALiquidia Corporation
2024/11/0422:00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024NASDAQ:LQDALiquidia Corporation
2024/10/2305:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/10/1904:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LQDALiquidia Corporation
2024/10/1609:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/10/1609:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/10/1609:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
2024/10/0723:00GlobeNewswire Inc.United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ PatentNASDAQ:LQDALiquidia Corporation
2024/10/0219:00GlobeNewswire Inc.Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)NASDAQ:LQDALiquidia Corporation
2024/09/3021:00GlobeNewswire Inc.Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual MeetingNASDAQ:LQDALiquidia Corporation
2024/09/1806:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/09/1622:41GlobeNewswire Inc.Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 MillionNASDAQ:LQDALiquidia Corporation
2024/09/1305:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/09/1205:41Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:LQDALiquidia Corporation
2024/09/1121:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/09/1121:29Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:LQDALiquidia Corporation
2024/09/1121:26GlobeNewswire Inc.Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing AgreementNASDAQ:LQDALiquidia Corporation
2024/09/1121:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
 검색 관련기사 보기:NASDAQ:LQDA

최근 히스토리

NYSE
CVX
Chevron
USOTC
ADDYY
Adidas (QX)
NYSE
VZ
Verizon Communications
FX
USDGBP
US Dollar vs Sterling
NYSE
BAC
Bank of America
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
CCOM
SILVER
SILVER
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지